Becle Fixed the U.S. Inventory Problem, Then Broke the Rest of the World

Depletions beat shipments in America for the first time in a year — while a 20-point shipment gap opened in EMEA and APAC, and the agave windfall quietly became every competitor's discount

CUERVO.MX · Earnings Call · 2026-10-29

The quarter that looked like a catastrophe and the one that looked like a delay

Becle's third quarter of 2026 is an optical disaster layered on a real problem. Consolidated net sales fell 15.3% to MXN 9.3 billion, gross margin collapsed from 56.1% to 51.1%, operating margin went from 28.6% to 12.0%, EBITDA dropped 57.9% to MXN 1.5 billion and net income fell 84.6% to MXN 633 million. Earnings per share of MXN 0.18 against MXN 1.15 a year earlier. A chunk of that is arithmetic. The prior-year quarter contained a MXN 753 million other-income gain tied to the b:oost divestiture and U.S. distribution settlements. Strip it out and the operating margin decline narrows from 1,660 basis points to 800. Constant-currency net sales fell 10.3%, or 9.6% excluding b:oost. Still awful — but a spirits company shrinking high-single-digits in constant currency is a demand-and-price story, not an accounting one. The genuinely new thing in this report is where the accounting noise now lives. For four quarters, Becle has explained its U.S. shipments-versus-depletions mismatch as the price of a distributor transition. This quarter that mismatch finally closed — and reopened somewhere else entirely.

Whack-a-mole with shipments

In the U.S. and Canada, the repair is real and it is the most encouraging datapoint in the release. Shipments declined 3% after declines of 23.8% in Q1 and 8.7% in Q2. Depletions actually grew 0.3%, versus declines of 9% and 4.7% in the two prior quarters. Transition markets grew roughly 4.6% while non-transition markets fell 3.1%. Proximo volumes fell 1.8% against a 3.2% market decline on Nielsen data through late September, and Becle took 10 basis points of volume share. Mauricio Vergara was unambiguous: “We are done with the stocking that we program at the first of the year to rebalancing our inventories... For 2027, I don't see any discrepancy in speaking about normal business in both transition and non-transition markets. Depletions should equal shipments.” — Mauricio Vergara, Chief Commercial Officer · 2026-10-29 Then Shane Hoyne described the rest of the world: “in Q3, Proximo depletions grew 2.9% whilst shipments declined -16%.” — Shane Hoyne, President of Proximo Spirits · 2026-10-29 A roughly 19-point gap — the exact shape of problem that tormented the U.S. business a year ago, now relocated to EMEA and APAC, blamed on weather-delayed shipments and a Middle East logistics blockade. Nadine Sarwat of Bernstein was blunt about it: “I think a lot of people were hugely surprised by how big the gap was this quarter.” — Nadine Sarwat, Analyst · 2026-10-29 Management promised a Q4 catch-up, with Hoyne saying “We should definitely see a catch-up in shipments in Q4. That we're clear on.” — Shane Hoyne, President of Proximo Spirits · 2026-10-29 The recurring gap between shipments is now the single most reliable feature of this equity story — always closing, never quite closed. Note the contrast with July's call, where the U.S. team insisted inventories were “pretty much at our target” — Mauricio Herrera, Executive - U.S. and Canada Region · 2026-07-24 — true, and insufficient, because the problem simply migrated.

The agave windfall became the industry's discount

Here is the deeper tension. For two years, cheap agave was Becle's margin engine — a keyword fixture through 2025 and into early 2026, with management crediting input costs and sugar content for gross-margin expansion and analysts circling the eventual return toward 60%. That language has vanished from the top of this quarter's vocabulary. Input costs were merely "stable." Cheap agave did not stop helping Becle. It stopped being a differentiator, because it handed less vertically integrated rivals the P&L room to cut price. Vergara's framing of the promotional environment is the most important sentence in the transcript: “the varied pricing that you're seeing on the market is not only restricted to tequila. It's across every single category so there's definitely a behavior in general by many competitors that are sacrificing margins regardless of the category they're in.” — Mauricio Vergara, Chief Commercial Officer · 2026-10-29 And the horizon, verbatim from a year ago on the October 2025 call: “I don't see the current dynamics changing at least for the next 18 months.” — Mauricio Herrera, President of U.S. and Canada Region · 2025-10-23 Same phrasing, same 18 months, one year older. When a management team re-issues an 18-month warning for four consecutive quarters, the 18 months is not a forecast — it's a rolling excuse, and it means the price war has now persisted longer than the window that supposedly contained it.

I personally don't see, we don't see any indication that at least in the next 18 months, the construction in the industry will revert or potentially slow down a little bit... We do see that this environment from aggressive pricing will continue at least into 2027.
Mauricio Vergara, Chief Commercial Officer · 2026-10-29

Mexico is the tell that the discipline is working but not paying. Organic volumes grew just 0.3% against an 18.3% prior-year comparison, year-to-date organic volume is up 3.7%, and the portfolio beat the industry on every Nielsen metric through August — yet reported net sales value still fell 9.3%. Outperforming a shrinking market while your own revenue falls at a high-single-digit rate is a definition of share gains that don't compound.

GLP-1: from unquantifiable to acknowledged

The other quiet shift is rhetorical. In February, asked about GLP-1, Vergara said it was “very difficult, almost impossible to estimate what an impact on tequila is on GLP-1.” — Mauricio Herrera, Executive, likely Head of U.S. and Canada Region · 2026-02-27 This quarter he volunteered a structural-versus-cyclical breakdown and conceded the structural part is real: “there's also a component that is structural in terms of moderated consumption, GLP-1, all the things that you mentioned that is impossible to quantify how much each one contributes. Even though those things are real, I still believe the biggest impact continues to be the economy.” — Mauricio Vergara, Chief Commercial Officer · 2026-10-29 The GLP 1 admission matters because the calorie-restriction wave is nobody's headwind alone — it is somebody else's tailwind. In the same five-day reporting window, Eli Lilly flagged a Medicare GLP-1 bridge program as a growth vector for obesity and diabetes franchises. Becle's structural demand leak and Lilly's volume ramp are the two ends of one trade, and only one side is currently being paid for it. The offset Becle offers is demographic, and it is genuinely new to the keyword set: new generation drinkers. Vergara argued Gen Z is entering legal drinking age in greater proportion than the prior cohort, and that in two to three years this turns from headwind to tailwind. It is unfalsifiable for eight quarters, which makes it rhetorically safe and analytically useless today.

What management stopped saying, and what that costs

Three silences are worth more than anything said on the call. First, agave benefit — a ranked theme for six straight quarters — is gone, because it no longer differentiates. Second, the RTD and non-alcoholic drag, a named culprit through 2025, has been largely retired now that b:oost is disposed. Third, guidance was quietly revised to a mid-single-digit constant-currency net sales decline, from the low-single-digit framing of February. That is a downgrade dressed in soft adjectives. Leverage is the constraint on all of it. Adjusted net leverage rose to 1.3x from 1.1x in the prior quarter — still inside the 1.0–1.5x target, but rising for the mechanical reason that trailing EBITDA shrank, not because debt rose. Total debt fell MXN 2.3 billion to MXN 19 billion and nine-month operating cash flow was MXN 5.2 billion, so the balance sheet is fine. Which makes the recurring M&A tease more conspicuous: for at least four consecutive calls, an analyst has asked about bolt-ons, and Juan Domingo Beckmann has said the same thing. This time: “we are always looking to see if there are interesting premium brands that could be acquired. As of now, we have not seen anything really appealing” — Juan Domingo Beckmann, CEO · 2026-10-29 — ideally above $30 a bottle. A spirits market in its worst pricing environment in a decade should be an acquirer's market. Becle keeps saying it's shopping and keeps coming home empty.

The read

The market-wide keyword tape offers Becle no tailwind whatsoever: the dominant global themes of the last twelve quarters are AI data centres, tariffs, memory pricing and grid equipment. Nothing in the broader market's editorial vocabulary is pulling a spirits recovery along. The genuine cross-currents are negative — a Middle east conflict that physically blocked shipments, and a challenged consumer trading down to accessible brands, which is precisely the mix Becle credited for its less favorable product mix. The honest summary: the mechanical problems are being solved in sequence, and management deserves credit for the U.S. repair. But the company is now shrinking in constant currency in all three regions while simultaneously telling investors that price competition will persist through 2027 and that a new generation will fix demand after that. Between those two dates sits the entire investment case, and no shipment catch-up in the fourth quarter changes what it says. Expect a Q4 headline that looks much better than this one for reasons that have nothing to do with demand.